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THE PHYSIOLOGICAL EFFECTS of adenosine have been observed in nearly every tissue and organ (1, 19, (32) (33) (34) (35) 53) . Adenosine plays an important role in cardiac protection (15) (16) (17) , as well as the maintenance of vascular tone via activation of four receptor subtypes (A 1 , A 2A , A 2B , and A 3 ). In blood vessels, vasodilation is primarily caused by the activation of A 2A AR (36 -39) . Moreover, A 2A AR-mediated relaxation was found to be dependent on the presence of a functional endothelium (1, 25, 36, 42) .
Several cytochrome P-450 (CYP)-epoxygenases, including members of the CYP2C (CYP2C29) and CYP2J (CYP2J2, CYP2J5) subfamilies, have been identified in vascular endothelial cells (13, 41, 63, 64) . Yang et al. (59) showed that overexpression of CYP2J2 protects endothelial cells against hypoxia-reoxygenation injury (59) . Ma et al. (28) found abundant CYP2J5 in both the kidney and liver. The CYP-epoxygenases add an epoxide group across one of the four double bonds of arachidonic acid, forming four EET regioisomers, 5,6-, 8,9-, 11,12-, and 14,15-EET. Endothelial cells express CYP2C and CYP2J, which are the main source of EETs generation in the vascular system (13, 41, 46) . The most potent biological effects of EETs occur in small-resistance vessels, as well as in the aorta (9, 36) . For example, 14,15-EET has been observed to produce relaxation of isolated coronary microvessels at concentrations as low as 10 pM (9) . This process occurs through hyperpolarization and suggests that the EETs function as an endothelium-derived hyperpolarizing factor (EDHF) in a number of vascular beds, including the coronary artery and aorta (3, 4, 13, 36, 37) . The EDHF response in bovine coronary arteries and mouse aorta is inhibited by the EET antagonist, 14,15-epoxyeicosa-5(Z)-enoic acid (14, 36) . The peroxisome proliferator-activated receptor (PPAR) transcription factors are members of the nuclear receptor superfamily that are activated by fatty acids and fatty acid derivatives (11) . Both PPAR␣ and PPAR␥ are expressed in blood vessels (5, 6) , indicating that they have a role in vascular function. PPAR␥ is activated when bovine aortic endothelial cells are exposed to laminar flow through a process that is dependent on CYP-epoxygenases (26) , and this leads to increases in the formation of 8,9-, 11,12-, and 14,15-EET in the endothelial cells within 15 min.
The soluble epoxide hydrolase (sEH) enzyme is detected in a variety of mammalian tissues, including the liver, kidney, intestine, and blood vessels (40, 56, 60) . Within these tissues, sEH metabolizes epoxide-containing compounds to their corresponding diols (31, 40) . Conversion of arachidonic acid epoxides to diols by sEH diminishes the beneficial cardiovascular properties of these epoxyeicosanoids. Inhibition of sEH causes EETs to accumulate and be retained for longer periods after they are formed (9) . Some reports provide further evidence that sEH inhibition may be an effective approach for the treatment of hypertension and diseases associated with vascular inflammation (7, 8, 18, 47, 61) . Also, the targeted disruption of the sEH gene in male mice lowers systolic blood pressure (51) . Recently, we found that there is a possible link between the upregulation of A 2A AR, CYP-epoxygenases, and downregulation of sEH with adenosine-induced relaxation in mouse aorta (38) . Also, we found that there is a possible link between the downregulation of A 2A AR, CYP-epoxygenases, and upregulation of sEH with 5=-N-ethylcarboxamidoadenosine (NECA)-induced contraction in mouse aorta (38, 39) . Therefore, we hypothesized that the lack of sEH enhances adenosine-induced vascular relaxation through A 2A AR via CYPepoxygenases and PPAR␥.
MATERIALS AND METHODS
The generation of sEH Ϫ/Ϫ mice was described by Sinal et al. (51) . sEH Ϫ/Ϫ and sEH ϩ/ϩ mice were provided by Dr. Zeldin, National Institute of Environmental Health Sciences/National Institutes of Health (NIH). All animal care and experimentation protocols were approved and carried out in accordance with the West Virginia University Institutional Animal Care and Use Committee and were in accordance with the principles and guidelines of the NIH's Guide for the Care and Use of Laboratory Animals. Both male and female mice (14 -18 wk old) in equal ratio were used in our study.
Protein extraction, gel electrophoresis, and Western blot analysis. Mice were killed with pentobarbital sodium (100 mg/kg ip). According to our previously described protocol (36 -39) , after thoracotomy, the aorta was gently removed and cleaned of fat and connective tissue. In brief, aortas from both sEH Ϫ/Ϫ and sEH ϩ/ϩ mice were treated with 1 ml of lysis buffer for protein extraction. Gel electrophoresis and Western blot analysis were done according to the protocol described by us (36 -39) . Following blocking with nonfat dry milk, the nitrocellulose membranes were incubated with polyclonal primary antibodies for CYP2J5 (Dr. Zeldin, NIEHS/NIH), A 1 AR (Sigma Chemicals), A2A AR (Alpha Diagnostic), CYP4A, PPAR␣, PPAR␥, and ␤-actin (Santa Cruz Biotechnology). The secondary antibody, horseradish peroxidase-conjugated anti-rabbit IgG, was used. The membranes were developed using enhanced chemiluminescence (Amersham Biosciences) and exposed to X-ray film for appropriate time.
sEH Ϫ/Ϫ and sEH ϩ/ϩ aortic rings. After thoracotomy the aorta was gently removed, cleaned of fat and connective tissue, and cut transversely into rings of 3-4 mm in length. Care was taken not to damage the endothelium. The rings were hung vertically between two wire hooks. Two rings were suspended in organ baths containing 10 ml of modified Krebs-Henseleit buffer (36 -39) . After the equilibration period (60 min), tissues were contracted with KCl (50 mM) to assess the viability of the tissue. Rings were then constricted with phenylephrine (PE; 10 Ϫ7 M), and tension was monitored continuously with a fixed range precision force transducer (125C; BIOPAC Systems) connected to amplifiers (Data Acquisition system 100B; BIOPAC Systems). Data were recorded using MP100 WSW, BIOPAC digital acquisition system and analyzed using Acknowledge 3.5.7 software (BIOPAC Systems). The functionality of endothelium was tested with ACh (10 Ϫ7 M) on precontracted (PE) rings, as previously described by our laboratory (36 -39 Statistical analysis. Statistical data were reported as means Ϯ SE. One-way ANOVA was used to compare difference among groups, and two-way ANOVA was used for repeated measures, followed by Tukey post hoc test to compare the NECA, CGS 21680, and GW 7647-induced vascular responses to antagonist (L-NAME, 14,15-EEZE, T0070907, ZM 241385, SCH 58261, AUDA, and t-AUCB). Differences were considered significant when P Ͻ 0.05. Further, densitometry of Western blot analysis (CYP2J5, CYP4A, PPAR␣, PPAR␥, A 2A AR, and A1AR) was expressed as means Ϯ SE in arbitrary units. All the statistical analyses were performed using GraphPad Prism statistical package.
RESULTS

Expression of A 2A AR, A 1 AR, CYP2J5, CYP4A, PPAR␣, and PPAR␥ proteins in aortas from sEH
Ϫ/Ϫ and sEHϩ/ϩ mice. Western blot analysis for A 2A AR (ϳ45 kDa) protein showed 31% more in sEH Ϫ/Ϫ than sEH ϩ/ϩ mouse aorta (P Ͻ 0.05, Fig. 1A ) whereas, A 1 AR (ϳ37 kDa) protein showed 30% less in sEH Ϫ/Ϫ than sEH ϩ/ϩ mice (P Ͻ 0.05, Fig. 1B ) . The amount of CYP2J5 (ϳ58 kDa) protein in sEH Ϫ/Ϫ was increased by 65% compared with sEH ϩ/ϩ mouse aorta (P Ͻ 0.05, Fig. 2A) . Further, the level of CYP4A (ϳ50 kDa) protein in sEH Ϫ/Ϫ was increased by 60% compared with sEH ϩ/ϩ mouse aorta (P Ͻ 0.05, Fig. 2B ). Western blot analysis for PPAR␥ (ϳ58 kDa) protein showed 36% more in sEH Ϫ/Ϫ than sEH ϩ/ϩ mouse aorta (P Ͻ 0.05, Fig. 3A ), whereas PPAR␣ (ϳ52 kDa) protein showed 27% less in sEH Ϫ/Ϫ than sEH ϩ/ϩ mice (P Ͻ 0.05, Fig. 3B ).
CRC for ACh and the effect of nitric oxide inhibitor in sEH
Ϫ/Ϫ and sEH ϩ/ϩ mice. ACh caused a concentration (10 Ϫ7 -10 Ϫ5 M)-dependent relaxation in both sEH Ϫ/Ϫ and sEH ϩ/ϩ , but the response was not significantly different (P Ͼ 0.05) between aortas from sEH Ϫ/Ϫ and sEH ϩ/ϩ (Fig. 4) . Also, L-NAME (100 M) had altered vascular response significantly (P Ͻ 0.05) in both sEH Ϫ/Ϫ (ϩ3.32 Ϯ 6.0% at 10 Ϫ6 ACh) and 
M CGS 21680 in sEH
ϩ/ϩ as opposed to its control (ϩ2.1 Ϯ 2.8%; Fig. 7B ). In contrast, t-AUCB had no significant effect on CGS 21680 CRC in sEH Ϫ/Ϫ (P Ͼ 0.05, Fig. 7B ).
CRCs for PPAR␣-agonist (GW 7647) and CGS 21680 and the effect of PPAR␥-antagonist (T0070907) in sEH
Ϫ/Ϫ and sEH ϩ/ϩ mice. GW 7647 produced a concentration-dependent contraction in both sEH Ϫ/Ϫ and sEH ϩ/ϩ mice (P Ͼ 0.05; Fig. 8A ). For example, at 10 Ϫ6 M GW 7647, the contraction response was Ϫ2.48 Ϯ 1.1% in sEH Ϫ/Ϫ compared with Ϫ6.52 Ϯ 1.4% in sEH ϩ/ϩ mice (P Ͼ 0.05; Fig. 8A ), while CGS 21680 produced a concentration-dependent enhanced relaxation in sEH Ϫ/Ϫ compared with less relaxation in sEH ϩ/ϩ mice (P Ͻ 0.05; Fig. 8B ). For example, at 10 Ϫ6 M CGS 21680, the relaxation response was ϩ37.4 Ϯ 5.4% in sEH Ϫ/Ϫ compared with ϩ2.1 Ϯ 2.8% in sEH ϩ/ϩ mice (P Ͻ 0.05; Fig. 8B ). In comparison between CGS 21680 and GW 7647, the CGS 21680 (10 Ϫ6 M)-induced relaxation response was ϩ37.4 Ϯ 5.4% in sEH Ϫ/Ϫ mice, whereas the GW 7647 (10 Ϫ6 M)-induced contraction response was Ϫ2.48 Ϯ 1.1% in sEH Ϫ/Ϫ mice (P Ͻ 0.05; Fig. 8, A and B) . Also, a significant blockade was found in the CRC of CGS 21680-induced relaxation with T0070907 (PPAR␥-antagonist; 0.1 M) compared with control in sEH Ϫ/Ϫ aortas. At 10 Ϫ6 M CGS 21680, T0070907 had changed the vascular response in sEH Ϫ/Ϫ (ϩ9.40 Ϯ 3.1%; Fig.  8C ) aortas compared with controls (ϩ37.46 Ϯ 5.4%, P Ͻ 0.05; Fig. 8C ).
DISCUSSION
The sEH Ϫ/Ϫ mice show an increase in aortic A 2A AR, CYP2J, and PPAR␥ protein expressions, and a decrease in A 1 AR, PPAR␣ proteins compared with sEH ϩ/ϩ mice (Figs. 1-3) . The relationship between sEH and adenosine-induced vascular responses in mice is not known. Therefore, this study was designed to investigate the role of A 2A , A 1 ARs, CYP-epoxygenases, PPAR␣, and PPAR␥ in sEH ϩ/ϩ and sEH Ϫ/Ϫ mice. Our data demonstrate that 1) ACh-induced vascular relaxation was not different between sEH Ϫ/Ϫ and sEH
mice, and L-NAME was able to block ACh-induced vascular relaxation equally in both sEH Ϫ/Ϫ and sEH ϩ/ϩ mice; 2) A 2A AR modulates nitric oxide (NO)-independent vascular relaxation in sEH Ϫ/Ϫ mice compared with sEH ϩ/ϩ ; 3) A 2A AR-mediated relaxation was blocked by EET receptor antagonist, but not with NO inhibitor; 4) sEH inhibitors (AUDA and t-AUCB) reversed the CGS 21680-mediated vascular response to enhanced relaxation in sEH ϩ/ϩ , but ineffective in sEH Ϫ/Ϫ mice; 5) CGS 21680 enhanced dose-dependent relaxation in sEH Ϫ/Ϫ mice, whereas GW 7647 (PPAR␣-agonist) reduced relaxation significantly, and finally 6) T0070907 (PPAR␥-antagonist) significantly inhibited the CGS 21680-enhanced vascular relaxation in sEH Ϫ/Ϫ mice. Genetic polymorphisms in CYP-epoxygenases have been observed in different populations, which affect cardiovascular function, including hypertension (10, 12, 20, 23, 54, 55, 57,  66 ). Genetic variation in sEH and CYP4A was also found in human population with risk of coronary heart disease, ischemic stroke, restenosis, diabetes heart, heart failure, ischemic stroke in white Europeans, Chinese populations, and in the African American population with hypertension (2, 10, 21, 24, 30, 66). As the earlier studies showed the differential renal sEH gene expression in prehypertensive, hypertensive, and spontaneously hypertensive rats (49) , and mice lacking A 2A AR have hypertensive characteristics (22) . Therefore, there is a need to identify the possible targets and develop novel pharmacological agents to treat vascular deregulation in patients in the long run, who have allelic variants that may possibly act similar to our gene-manipulated mice (A 2A AR Ϫ/Ϫ , sEH Ϫ/Ϫ ), which may be involved in the regulation of blood pressure and vascular tone.
ACh data between sEH ϩ/ϩ and sEH Ϫ/Ϫ suggest that there is no relationship between ACh and the presence or absence of sEH (Fig. 4) . Also, L-NAME, a nitric oxide synthase inhibitor completely blocked ACh-induced vascular response equally in both sEH ϩ/ϩ and sEH Ϫ/Ϫ mice (Fig. 4) .These data also suggest that the presence or absence of sEH does not matter in ACh-induced vascular response in both sEH ϩ/ϩ and sEH Ϫ/Ϫ mice (Fig. 4) . Similarly, Zhang et al. (65) reported that the inhibition of sEH ameliorates endothelial dysfunction and effects in the db/db mice, which is independent of NO, but dependent on CYP-epoxygenase-derived metabolites. Other studies have also shown that nitric oxide synthase inhibition does not affect the increase of blood flow in forearm or leg during exercise in humans, rats, and rabbits (43, 44, 50, 58) . But, during exercise, adenosine originates from skeletal muscle fibers and acts on A 2A AR to evoke vasodilatation independent of NO (45). Our own studies have shown that adenosine- induced mouse aortic relaxation through A 2A AR is independent of NO and COX (36 -38) .
The sEH enzyme metabolizes EET that serve as substrates for the sEH (31, 40) . The conversion of EETs in the presence sEH into the corresponding dihydroxyeicosatrienoic acids (DHETs) results in loss of beneficial effects (29, 52, 62) . The conversion of epoxides to diols by sEH diminishes the beneficial cardiovascular properties of these epoxyeicosanoids. Inhibition of sEH causes EETs to accumulate and be retained for longer periods after they are formed (9) . Some reports provide further evidence that sEH inhibition may be an effective approach for the treatment of hypertension and diseases associated with vascular inflammation (7, 8, 18, 47, 61) . Also, the targeted disruption of the sEH gene in male mice lowers systolic blood pressure (51) . Recently, we found that there is a possible link between the upregulation of A 2A AR, CYPepoxygenases, and downregulation of sEH with adenosineinduced relaxation in high-salt diet-fed WT mice (C57BL/6J) and eNOS Ϫ/Ϫ (C57BL/6J background) compared with low-salt diet-fed mice (38, 39) . Also, we found that there is a possible link between the downregulation of A 2A AR, CYP-epoxygenases and upregulation of sEH with NECA-induced contraction in low-salt diet-fed WT mice and eNOS Ϫ/Ϫ (C57BL/6J background) compared with high-salt diet-fed mice (38, 39) . The current study shows that in the absence of sEH, there is an increase in aortic A 2A AR, CYP2J5, PPAR␥, and a decrease in A 1 AR, PPAR␣ proteins compared with WT mice. Therefore, we hypothesize that, in the absence of sEH, adenosine induces vascular relaxation through A 2A AR via CYP-epoxygenases and PPAR␥, whereas in the presence of sEH, adenosine induces vascular contraction through PPAR␣.
NECA (nonselective adenosine agonist) induces significant relaxation in sEH Ϫ/Ϫ compared to sEH ϩ/ϩ mice (Fig. 5 ), suggesting that sEH deletion enhances NECA-induced vascular relaxation. Our data show that NECA-induced vascular response in aortas of sEH Ϫ/Ϫ mice is similar to that from our earlier reports in which we found that high-salt diet-fed WT (C57BL/6J) mice had an enhanced NECA-induced relaxation with upregulation of A 2A AR, CYP2J-epoxygenase and downregulation of sEH, whereas, NECA-induced vascular response in aortas of sEH ϩ/ϩ mice is similar to that found in our earlier reports in which low-salt diet-fed WT (C57BL/6J) mice had an enhanced NECA-induced contraction with downregulation of A 2A AR, CYP2J-epoxygenase and upregulation of sEH (37, 38) . Therefore, in the present study, we used specific A 2A AR antagonists (ZM-241385 and SCH-58261) to rule out the involvement of other adenosine receptors (A 1 , A 2B , A 3 ). Both ZM 241385 and SCH-58261 (A 2A AR-antagonists) blocked completely the NECA-induced vascular relaxation in sEH Ϫ/Ϫ compared with untreated mice (Fig. 5, A and B) . We also confirmed the involvement of A 2A AR with the use of a highly selective A 2A AR agonist (CGS 21680) in sEH ϩ/ϩ and sEH Ϫ/Ϫ mouse aortas. A highly robust CGS 21680-induced vascular relaxation was observed in sEH Ϫ/Ϫ compared with sEH ϩ/ϩ mice (Fig. 6) . Also, in the present study, we found a significant upregulation of A 2A AR protein in sEH Ϫ/Ϫ compared with sEH ϩ/ϩ mice (Fig. 1A) , whereas a significant downregulation of A 1 AR protein in sEH Ϫ/Ϫ compared with sEH ϩ/ϩ mice (Fig.  1B) . These data suggest that A 2A AR is the only adenosine receptor involved in enhancing adenosine-induced relaxation in sEH Ϫ/Ϫ compared with sEH ϩ/ϩ mouse aortas.
In the present study, we also tested whether A 2A AR-induced vascular relaxation is NO-dependent or not. No significant changes were found between L-NAME-treated and untreated sEH Ϫ/Ϫ and sEH ϩ/ϩ mouse aorta with CGS 21680-induced vascular response (Fig. 6A) . These data suggest that there is no role for NO in adenosine-induced vascular response through A 2A AR in sEH Ϫ/Ϫ and sEH ϩ/ϩ mice. These data confirm our earlier reports from this laboratory in which L-NAME and indomethacin (COX inhibitor) were unable to block aortic relaxation in A 2A AR ϩ/ϩ compared with A 2A AR Ϫ/Ϫ mice, and in high-salt diet-fed compared with low-salt diet-fed C57BL/6J mice (36 -39) . Also, Ray and Marshall (45) reported that during exercise, skeletal muscle fibers release adenosine, which is independent of NO.
In this study, NECA-and CGS 21680-induced relaxation in sEH Ϫ/Ϫ mouse aortas (Figs. [5] [6] [7] [8] suggests that this relaxation depends on A 2A AR via CYP-epoxygenases leading to EETs formation. Therefore, we were able to block CGS 21680-induced vascular relaxation with 14,15-EEZE (EET receptor antagonist) in sEH Ϫ/Ϫ mouse aortas (Fig. 6B) . Similarly, the EDHF response in bovine coronary arteries was inhibited by the EET antagonist, 14,15-epoxyeicosa-5(Z)-enoic acid (14) . Recently, a report from our laboratory also showed that in A 2A AR ϩ/ϩ mouse aorta, the adenosine-induced vascular relaxation was inhibited by the EET antagonist, 14,15-epoxyeicosa-5(Z)-enoic acid (36) . In the present study, we also found an upregulation of CYP2J5 proteins in sEH Ϫ/Ϫ compared with sEH ϩ/ϩ mouse aortas ( Fig. 2A) . Our data suggest that the endotheliumdependent NECA-and CGS-21680-induced vascular relaxation is mediated through EETs possibly by increased in CYP2J-epoxygenase in sEH Ϫ/Ϫ compared sEH ϩ/ϩ mouse aortas. The current study further confirmed that the adenosineinduced vascular relaxation through A 2A AR is dependent on CYP-epoxygenases, including CYP2J-epoxygenase, but not NO or COX.
We also demonstrated that the treatment with 12-(3-adamantan-1-yl-ureido) dodecanoic acid (AUDA) or trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB), inhibitors of the sEH enzyme have reversed the CGS 21680-induced weak vascular response into a strong vascular relaxation in sEH ϩ/ϩ compared with controls (Fig. 7, A and B) , while, no significant change was observed with AUDA or t-AUCB treated and untreated sEH Ϫ/Ϫ mice (Fig. 7, A and B) . These data suggest that, in the presence of sEH, AUDA or t-AUCB effectively block the endogenous sEH enzyme activity. Therefore, we observed complete reversal of CGS 21680-induced vascular response in AUDA-or t-AUCB-treated sEH ϩ/ϩ mouse aortas compared with controls. Also, it is obvious that, no significant change was observed with CGS 21680-induced vascular response between AUDA or t-AUCBtreated and untreated sEH Ϫ/Ϫ mice, because these mice do not have endogenous sEH enzyme activity. Use of sEH enzyme inhibitors or deleting the sEH gene increases endogenous EETs by decreasing the metabolic conversion of EETs into less active DHETs. If the mechanism by which sEH inhibitors (AUDA or t-AUCB) or deletion of sEH gene enhance CGS 21680-induced vascular relaxation occurs by increasing endogenous EET levels, then it would be expected that inhibiting EET synthesis would attenuate the CGS 21680-induced vascular response in sEH Ϫ/Ϫ mice. As expected, pretreatment of sEH Ϫ/Ϫ mouse aorta with the EETs antagonist 14,15-EEZE did alter significantly CGS 21680-induced vascular response from relaxation to contraction (Fig. 6B) . These data suggest that in absence or blocking of sEH, enhanced CGS 21680-induced vascular relaxation is mostly likely due to an increase EET levels. Liu et al. (26) suggests that selective sEH inhibitors will potentiate the anti-inflammatory effect in the endothelial cells, presumably by increasing the retention of 11,12-and 14,15-EET so that PPAR␥ activation is prolonged. Acute activation of PPAR␥ leads to endothelium-dependent aortic relaxation in nondiabetic (ϩdb/ϩm) mice (48) . Therefore, we found upregulation of PPAR␥ and down regulation of PPAR␣ with A 2A AR enhanced relaxation in sEH Ϫ/Ϫ compared with sEH ϩ/ϩ mice (Fig. 3, A and B) . The PPAR expression data are also supported by the functional data, in which PPAR␣ agonist dose-dependent vascular response in sEH Ϫ/Ϫ was not significantly different compared with sEH ϩ/ϩ mice (Fig. 8A) , whereas CGS 21680 dose-dependent vascular response in sEH Ϫ/Ϫ was significantly different compared with sEH ϩ/ϩ mice (Fig. 8B ). There was no significant difference found between CGS 21680-induced vascular response in sEH ϩ/ϩ mice compared with PPAR␣-agonist-induced response in both sEH Ϫ/Ϫ and sEH ϩ/ϩ mice (Fig. 8, A and B) , suggesting that the vascular contraction in sEH ϩ/ϩ mouse aorta is possible due to PPAR␣ activity (Figs. 3B and 8A). Moreover, PPAR␥ antagonist was able to block significantly the CGS 21680-induced vascular relaxation (Fig. 8C) , and there was no significant difference found between CGS 21680-induced vascular response in sEH ϩ/ϩ mice compared with CGS 21680 ϩ PPAR␥ antagonist response in both sEH Ϫ/Ϫ and sEH ϩ/ϩ -treated mice (Fig. 8C ). These data suggest a possible role for PPAR␥ in CGS 21680-induced vascular relaxation in the absence of sEH compared with the presence of sEH in mice (Figs. 3A and 8C) . Also, the data suggest a possible role of PPAR␣ in vascular contraction (Figs. 3B and 8A) . Surprisingly, we found an upregulation of CYP4A (Fig. 2B ), a vasoconstrictor enzyme in sEH Ϫ/Ϫ mouse aorta compared with sEH ϩ/ϩ . The reason behind the upregulation of CYP4A in the absence of sEH may be due to a compensatory response to maintain vascular tone, as well as the blood pressure in sEH knockout mouse. Similar upregulation of CYP4A in kidneys of Ephx2 gene-disrupted mice has been reported as a compensatory mechanism to maintain blood pressure regulation (27) .
The present data suggest that there is a relationship between A 2A AR-enhanced vascular relaxation and lack of sEH, and there is relationship between the presence of sEH and adenosine-induced vasoconstriction or less relaxation through upregulation of A 1 AR. The signaling mechanism may be involved by the activation of A 2A AR, functional endothelium to activate CYP2J-epoxgenases to generate more EETs than DHETs, downregulation of A 1 AR, PPAR␣, and upregulation of A 2A AR, PPAR␥, leading to NECA or CGS 21680-enhanced vascular relaxation in sEH Ϫ/Ϫ mouse aorta. In contrast, the contraction or less relaxation with NECA or CGS 21680 in sEH ϩ/ϩ mice provides evidence that there is a possible link among the less availability of A 2A AR, less functional endothelium to activate CYP2J-epoxygenases, less generation of EETs than DHETs, and upregulation of A 1 AR and PPAR␣. Therefore, we conclude that upregulation of CYP-epoxygenases, A 2A AR, and PPAR␥ and downregulation of A 1 AR and PPAR␣ protein expression contribute to NECA-or CGS 21680-induced dilation in sEH Ϫ/Ϫ mouse aorta, while the upregulation of A 1 AR and PPAR␣ and downregulation of CYP-epoxygenases, A 2A AR, and PPAR␥ protein expression contribute to NECA or CGS 21680-induced vasoconstriction or less relaxation in sEHϩ/ϩ mouse aorta.
Perspectives and Significances
These findings suggest that the relationship among A 2A AR, CYP-epoxygenases, arachidonic acid-derived metabolites, and PPAR␥ in vasodilation, while a relationship among A 1 AR, sEH, and PPAR␣ in vasoconstriction may have clinical implication in the regulation of vascular tone and regulation of blood pressure. Any deregulation in these pathways or slight allelic variations may possibly lead to hypertension and coronary artery disease in humans. Future studies are necessary to identify the possible targets and develop novel pharmacological agents to treat vascular deregulation in patients in the long run, who have allelic variants that may possibly act similar to our gene-manipulated mice (A 2A AR Ϫ/Ϫ , sEH Ϫ/Ϫ ), which may play a role in the regulation of vascular tone and ultimately blood pressure.
